Metabolic Aspects of Myelinating Glia

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 305

Special Issue Editors


E-Mail Website
Guest Editor
Department of Basic Science, Faculty of Medicine, University of Crete and IMBB-FORTH, Crete, Greece
Interests: myelination in the CNS; axoglial interactions; interneurons; neuronal migration

E-Mail Website
Guest Editor
Department of Neuroscience, The Cyprus Institute of Neurology and Genetics and Cyprus School of Molecular Medicine, Nicosia, Cyprus
Interests: demyelinating disorders; inherited neuopathies; multiple sclerosis; myelinating glia; gene therapy

Special Issue Information

Dear Colleagues,

Myelinating cells surround axons of the central (CNS) and peripheral (PNS) nervous systems and produce the myelin sheath to accelerate the propagation of action potentials, to support axonal health, and to refine neural circuits. Myelination is a metabolically demanding process. Findings from studies of axon-glial interactions indicate a crucial role of glial cells in the metabolic support of axon that is independent of myelination itself. In this Special Issue on metabolic aspects of myelinating glia, we plan to include work that provides novel insights into the metabolism of myelinating glia in health and disease. Glial metabolism includes the contribution of myelin itself, due to its high lipid content, to provide white matter energy balance and axonal metabolic support.  Due to this energy consuming process and the associated high metabolic turnover, oligodendrocytes, the myelinating glia of the CNS, are vulnerable to cytotoxic and excitotoxic factors. Energy requirements on other glial cells that are known to interact with oligodendrocytes/Schwann cells and influence their development and function, such as astrocytes and microglia, are also going to be included. Specific molecular pathways such as mTOR, myelinophagy, fatty-acid oxidation and other mechanisms will be discussed. Manipulation and alterations of these and other relevant pathways will be discussed, since they may underlie different types of degenerative pathologies. Finally, the opportunity to use myelinating glia-axon metabolic interactions as therapeutic targets to treat CNS and PNS degenerative disorders will also be addressed.

Prof. Dr. Domna Karagogeos
Prof. Dr. Kleopas A. Kleopa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oligodendrocytes
  • Schwann cells
  • myelin
  • mTOR
  • autophagy
  • fatty acids
  • glia-axon interactions
  • mitochondrial metabolism
  • multiple sclerosis
  • leukodystrophy
  • peripheral neuropathies

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop